Combined treatment with ibuprofen and the AT1 receptor antagonist candesartan in young spontaneously hypertensive rats

Journal of the American Society of Nephrology

Volumn 10, Issue 1 SUPPL. 11, 1999, Pages

  Pollock, David M ^a   Morsing, Peter ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN HEXETIL; IBUPROFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD FLOW VELOCITY; DIURESIS; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; FLUID INTAKE; KIDNEY BLOOD FLOW; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION; URINE VOLUME;

EID: 0032928393     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Abe K, Ito T, Sato M, Harayuma T, Sato K, Omata K, Hiwatari M, Sakurai Y, Imai Y, Yoshinaga K: Role of prostaglandins in the antihypertensive mechanism of captopril in low renin hypertension. Clin Sci 59: S141-S144, 1980
2. Brown J, Dollery C, Valdes G: Interaction of nonsteroidal anti-inflammatory drugs with antihypertensive and diuretic agents. Am J Med 81[Suppl 2B]: 43-57, 1986
3. Oates JA: Antagonism of antihypertensive drug therapy by non-steroidal anti-inflammatory drugs. Hypertension 11[Suppl]: II4-II6, 1988
4. Polónia J: Interaction of antihypertensive drugs with anti-inflammatory drugs. Cardiology 88[Suppl 3]: 47-51, 1997
5. Allon M, Pasque CB, Rodriguez M: Interaction of captopril and ibuprofen on glomerular and tubular function in humans. Am J Physiol 259: F233-F238, 1990
6. Morimoto S, Ogihara T: TCV-116: A new angiotensin II type-I receptor antagonist. Cardiovasc Drug Rev 12: 153-164, 1994
7. Sever P: Candesartan cilexetil: A new, long-acting, effective angiotensin II type 1 receptor blocker. J Hum Hypertens 11[Suppl 2]: S91-S95, 1997
8. Pollock DM, Polakowski JS, Divish BJ, Opgenorth TJ: Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension 21: 660-666, 1993
9. Pollock DM, Polakowski JS, Opgenorth TJ, Pollock JS: Role of ETA receptors in the hypertension produced by 4-day L-NAME and cyclosporine treatment. Eur J Pharmacol 346: 43-50, 1998
10. Johnson AG, Nguyen TV, Day RO: Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 121: 289-300, 1994
11. Radack K, Deck C: Do nonsteroidal anti-inflammatory drugs interfere with blood pressure control in hypertensive patients? J Gen Intern Med 2: 108-112, 1987
12. 2 synthesis. Hypertension 13: 754-758, 1989
13. Cachofeiro V, Sakakibara T, Nasjletti A: Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension. Hypertension 19: 138-145, 1992
14. Fenoy FF, Milicic I, Smith RD, Wong PC, Timmermans PB-MWM, Roman R: Effects of DuP 753 on renal function of normotensive and spontaneously hypertensive rats. Am J Hypertens 4: S321-S326, 1991
15. Cachofeiro V, Maeso R, Rodrigo E, Navarro J, Ruilope LM, Lahera V: Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension. Hypertension 26: 236-243, 1995